Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following investor conferences in October and November 2019.


Conference details:

Investir Day 1st Edition
Date:                     Thursday, October 3, 2019
Presentation time:  12:45 p.m. CEDT
Location:                Paris, France
 
CF&B Communication European Large & Midcap Event 19th Edition
Date:                     October 14-15, 2019
Location:                Paris, France
 
Bryan, Garnier & Co European Healthcare Conference
Date:                     Wednesday, November 13, 2019
Location:                Paris, France
 
Finance Avenue 2019
Date:                     Saturday, November 16, 2019
Presentation Time:  12:55 p.m. CEDT
Location:                Brussels, Belgium
 
Jefferies 2019 London Healthcare Conference
Date:                      November 20 - 21, 2019
Location:                 London, United Kingdom

Download press release(s)

Press release

61.84 Ko

Communiqué de presse

84.71 Ko

Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeti...

Next News

Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeti...